LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.
Novo Nordisk (0QIU) Gets a Buy from Goldman Sachs
In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...
Copenhagen Post5h
Flex job workers may receive billions after a court decision
The last Friday the Supreme Court ruled in favor of the Danish union FOA in a case against the Danish Labour Market Insurance (AES) and the Appeals Board. The decision could lead to compensation ...
Jim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price Negotiations
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
Biden adds weight loss drugs to Medicare price negotiations
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.